Clinical trial
A Prospective, Multicenter, Single Group Assignment Study for Evaluating the Safety and Effectiveness of MitralStitch Mitral Valve Repair System in Patients With Moderate to Severe and Severe Mitral Regurgitation.
NCT04080362 is registered in ClinicalTrials.gov with Hangzhou Valgen Medtech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Group Assignment Study for Evaluating the Safety and Effectiveness of MitralStitch Mitral Valve Repair System in Patients With Moderate to Severe and Severe Mitral Regurgitation.
- Lead sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 5, 2019
- Completion date
- June 1, 2022
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral regurgitation